Marie Perrin

Marie Perrin is a researcher specializing in biochemistry and structural biology with a focus on cancer therapeutics. She completed her PhD at Paris-Saclay University in 2022 with research centered on histone chaperone ASF1 inhibitors.

Her primary research interests include:

• Biochemistry and structural mechanisms of histone chaperones
• Development of cancer therapeutics through molecular inhibition
• Optimization of foldamer inhibitors through backbone plasticity

Dr. Perrin's recent work demonstrates expertise in molecular design targeting epigenetic regulators, with potential applications in novel cancer treatment strategies. Her publications show consistent focus on the ASF1 histone chaperone system and inhibitor development.

As an early-career researcher, she has established a focused research trajectory in biochemical oncology with publications appearing in 2022. Her work bridges structural biology and therapeutic chemistry to develop new approaches for cancer treatment.